Federated Hermes
CRTX

Federated Hermes’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

Federated Hermes’s Portfolio CRTX Stock Details CRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-8,026
Closed -$76K – 1842
2013
Q3 		$76K Buy
+8,026
New +$72.3K ﹤0.01% 1595

Other funds holding CRTX

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HA
Havens Advisors New York $39.3M AUM 80.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $480M AUM 8% 1-Year Est. Return

Federated Hermes's CRTX Position: Q4 2013 in Review

Federated Hermes sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q4 2013, closing a stake of 8,026 shares — an estimated $76K sold.

Federated Hermes first reported a position in CRTX in Q3 2013 and held it in 1 quarter. The position peaked at $76K in Q3 2013. 62 funds tracked by Wall St. Rank hold CRTX as of Q4 2013.

  • Federated Hermes reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q4 2013 after selling out during the quarter.
  • Federated Hermes sold 8,026 CORNERSTONE THERAPEUTICS INC shares in Q4 2013, an estimated $76K.
  • Federated Hermes first reported a position in CORNERSTONE THERAPEUTICS INC in Q3 2013 and held it in 1 quarter.
  • Federated Hermes's CORNERSTONE THERAPEUTICS INC position peaked at $76K in Q3 2013.
  • 62 funds tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q4 2013.

Based on Federated Hermes's 13F filing for Q4 2013, filed 11 Feb 2014.